New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 20, 2012
10:00 EDTCLNE, PANW, SIX, TDC, UNH, MDCO, RLGY, MPLX, JNJ, ISRG, COV, COH, CFN, BSX, AETOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Aetna (AET) initiated with a Buy at Lazard Capital... Boston Scientific (BSX) initiated with a Buy at Stifel Nicolaus... CareFusion (CFN) initiated with a Buy at Stifel Nicolaus... Coach (COH) initiated with an Outperform at Wells Fargo... Covidien (COV) initiated with a Buy at Brean Capital... Intuitive Surgical (ISRG) initiated with a Hold at Stifel Nicolaus... Johnson & Johnson (JNJ) initiated with a Hold at Stifel Nicolaus... MPLX (MPLX) initiated with a Neutral at UBS... Realogy (RLGY) initiated with a Neutral at Goldman... The Medicines Co. (MDCO) initiated with an Outperform at Oppenheimer... UnitedHealth (UNH) initiated with a Buy at Lazard Capital... Teradata (TDC) initiated with an Outperform at Credit Suisse... Six Flags (SIX) initiated with a Neutral at Longbow... Palo Alto (PANW) initiated with a Neutral at Nomura... Clean Energy (CLNE) initiated with a Buy at Dougherty.
News For AET;BSX;CFN;COH;COV;ISRG;JNJ;MPLX;RLGY;MDCO;UNH;TDC;SIX;PANW;CLNE From The Last 14 Days
Check below for free stories on AET;BSX;CFN;COH;COV;ISRG;JNJ;MPLX;RLGY;MDCO;UNH;TDC;SIX;PANW;CLNE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
September 5, 2014
08:41 EDTJNJJohnson & Johnson initiated with an Outperform at BMO Capital
Target $118.
07:09 EDTCOHCoach volatility increases
Subscribe for More Information
September 4, 2014
12:49 EDTUNH, AETJudges to revisit ObamaCare subsidies decision, The Hill reports
Subscribe for More Information
11:05 EDTJNJJ&J unit Janssen receives orphan status for whipworm treatment
Subscribe for More Information
10:29 EDTTDCOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:10 EDTTDCBarclays' top ideas in U.S. Software for 2H 2014
Subscribe for More Information
08:07 EDTTDCTeradata assumed with a Sector Perform at Pacific Crest
Subscribe for More Information
08:05 EDTPANWPalo Alto remains a top pick at Morgan Stanley
Subscribe for More Information
07:17 EDTCFNCareFusion management to meet with Deutsche Bank
Subscribe for More Information
07:16 EDTPANWPalo Alto weekly volatility elevated into Q4 and outlook
Palo Alto September 12 weekly call option implied volatility is at 63, September is at 51, October is at 46, December is at 41; compared to its 2-week average of 46 according to Track Data, suggesting large near term price movement into the expected release of Q4 results on September 9.
05:36 EDTTDCTeradata downgraded to Equal Weight from Overweight at Barclays
Barclays downgraded Teradata to Equal Weight citing headwinds from increased big data tool usage. The firm keeps a $46 price target for shares.
05:23 EDTJNJJohnson & Johnson to fast-track development of Ebola combination vaccine regimen
Subscribe for More Information
September 3, 2014
14:55 EDTUNH, AETObamaCare business exchange to launch in 5 states next month, The Hill says
Subscribe for More Information
10:40 EDTPANWAnalyst sees security 'spending frenzy' amid high-profile hacks
Subscribe for More Information
09:08 EDTTDCTeradata acquires Think Big Analytics
Subscribe for More Information
06:44 EDTPANWSecurity market demand 'rapidly' improving, says Piper Jaffray
Subscribe for More Information
06:34 EDTAET, UNHNext Obamacare enrollment period may be very difficult, NY Times says
Subscribe for More Information
September 2, 2014
15:00 EDTJNJWright Medical hip suit weakness would be buying opportunity, says Brean Capital
Subscribe for More Information
08:07 EDTBSXBoston Scientific closed agreement to acquire Interventional business of Bayer
Boston Scientific (BSX) closed on its previously announced agreement to purchase the Interventional business of Bayer (BAYRY). The addition of the Bayer Interventional strong commercial organization and innovative technologies supports the Boston Scientific strategy to provide a comprehensive portfolio of solutions to treat peripheral vascular disease. The transaction includes the leading AngioJet Thrombectomy System and the Fetch 2 Aspiration Catheter, which are used in endovascular procedures to remove blood clots from blocked arteries and veins, and the JetStream Atherectomy System, used in an innovative and fast-growing therapy to remove plaque and thrombi from diseased arteries.
07:55 EDTPANWPalo Alto business appears to be beating expectations, says Oppenheimer
Oppenheimer reports that its checks indicate that Palo Alto's business is tracking ahead of consensus estimates this quarter. The firm raised its price target on the shares to $90 from $80 and keeps an Outperform rating on the stock.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use